Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BISPECIFIC ANTIBODY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 177 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Marshall, KW; Marks, JD
      Engineering and characterization of a novel fusion protein incorporating B7.2 and an anti-ErbB-2 single-chain antibody fragment for the activation ofjurkat T cells

      JOURNAL OF IMMUNOTHERAPY
    2. Schwaab, T; Lewis, LD; Cole, BF; Deo, Y; Fanger, MW; Wallace, P; Guyre, PM; Kaufman, PA; Heaney, JA; Schned, AR; Harris, RD; Ernstoff, MS
      Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI Xanti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu

      JOURNAL OF IMMUNOTHERAPY
    3. Eccles, SA
      Monoclonal antibodies targeting cancer: 'magic bullets' or just the trigger?

      BREAST CANCER RESEARCH
    4. Schlehuber, S; Skerra, A
      Duocalins: Engineered ligand-binding proteins with dual specificity derived from the lipocalin fold

      BIOLOGICAL CHEMISTRY
    5. Schoonjans, R; Willems, A; Schoonooghe, S; Leoen, J; Grooten, J; Mertens, N
      A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain

      BIOMOLECULAR ENGINEERING
    6. Gruaz-Guyon, A; Janevik-Ivanovska, E; Raguin, O; De Labriolle-Vaylet, C; Barbet, J
      Radiolabeled bivalent haptens for tumor immunodetection and radioimmunotherapy

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    7. van Ojik, HH; Valerius, T
      Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    8. Xu, YF; Yang, CZ; Zhu, ZP
      Bispecific antibody and its clinical applications in cancer

      CHINESE SCIENCE BULLETIN
    9. Goodwin, DA; Meares, CF
      Advances in pretargeting biotechnology

      BIOTECHNOLOGY ADVANCES
    10. Goel, A; Batra, SK
      Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer

      TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS
    11. Gestin, JF; Loussouarn, A; Bardies, M; Gautherot, E; Gruaz-Guyon, A; Sai-Maurel, C; Barbet, J; Curtet, C; Chatal, JF; Faivre-Chauvet, A
      Two-step targeting of xenografted colon carcinoma using a bispecific antibody and Re-188-labeled bivalent hapten: Biodistribution and dosimetry studies

      JOURNAL OF NUCLEAR MEDICINE
    12. Todorovska, A; Roovers, RC; Dolezal, O; Kortt, AA; Hoogenboom, HR; Hudson, PJ
      Design and application of diabodies, triabodies and tetrabodies for cancertargeting

      JOURNAL OF IMMUNOLOGICAL METHODS
    13. Stockmeyer, B; Elsasser, D; Dechant, M; Repp, R; Gramatzki, M; Glennie, MJ; van de Winkel, JGJ; Valerius, T
      Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies

      JOURNAL OF IMMUNOLOGICAL METHODS
    14. Wallace, PK; Kaufman, PA; Lewis, LD; Keler, T; Givan, AL; Fisher, JL; Waugh, MG; Wahner, AE; Guyre, PM; Fanger, MW; Ernstoff, MS
      Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo

      JOURNAL OF IMMUNOLOGICAL METHODS
    15. Riesenberg, R; Buchner, A; Pohla, H; Lindhofer, H
      Lysis of prostate carcinoma cells by trifunctional bispecific antibodies (alpha EpCAM x alpha CD3)

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    16. Ford, CHJ; Osborne, PA; Rego, BG; Mathew, A
      Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen-expressing colon cancer cell lines in vitro and in vivo

      INTERNATIONAL JOURNAL OF CANCER
    17. Manzke, O; Tesch, H; Borchmann, P; Wolf, J; Lackner, K; Gossmann, A; Diehl, V; Bohlen, H
      Locoregional treatment of low-grade B-cell lymphoma with CD3 x CD19 bispecific antibodies and CD28 costimulation: I. Clinical phase I evaluation

      INTERNATIONAL JOURNAL OF CANCER
    18. Manzke, O; Tesch, H; Lorenzen, J; Diehl, V; Bohlen, H
      Locoregional treatment of low-grade B-cell lymphoma with CD3 x CD19 bispecific antibodies and CD28 costimulation: II. Assessment of cellular immune responses

      INTERNATIONAL JOURNAL OF CANCER
    19. Hassfjell, S; Brechbiel, MW
      The development of the alpha-particle emitting radionuclides Bi-212 and Bi-213, and their decay chain related radionuclides, for therapeutic applications

      CHEMICAL REVIEWS
    20. Maublant, J; Lumbroso, J; Cachin, F; Raoul, JL; Syrota, A; Vuillez, JP
      Nuclear medicine in oncology: New diagnostic and therapeutic methods

      BULLETIN DU CANCER
    21. James, ND; Atherton, PJ; Jones, J; Howie, AJ; Tchekmedyian, S; Curnow, RT
      A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+advanced prostate cancer

      BRITISH JOURNAL OF CANCER
    22. Wu, AM; Yazaki, PJ
      Designer genes: recombinant antibody fragments for biological imaging

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    23. de Labriolle-Vaylet, C; Cattan, P; Sarfati, E; Wioland, M; Billotey, C; Brocheriou, C; Rouvier, E; de Roquancourt, A; Rostene, W; Askienazy, S; Barbet, J; Milhaud, G; Gruaz-Guyon, A
      Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery

      CLINICAL CANCER RESEARCH
    24. Cao, Y; Suresh, MR
      Bispecific MAb aided liposomal drug delivery

      JOURNAL OF DRUG TARGETING
    25. de Boisferon, MH; Raguin, O; Dussaillant, M; Rostene, W; Barbet, J; Gruaz-Guyon, A
      Enhanced targeting specificity to tumor cells by simultaneous recognition of two antigens

      BIOCONJUGATE CHEMISTRY
    26. Fracasso, G; Colombatti, M
      Effect of therapeutic macromolecules in spheroids

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    27. Yang, CC; Chan, HL
      Immunochemical studies on beta(1)-Bungarotoxin

      ZOOLOGICAL STUDIES
    28. Weiner, LM; Adams, GP
      New approaches to antibody therapy

      ONCOGENE
    29. Hosono, MN; Hosono, M; Mishra, AK; Faivre-Chauvet, A; Gautherot, E; Barbet, J; Knapp, FF; Chatal, JF
      Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer

      ANNALS OF NUCLEAR MEDICINE
    30. Bremers, AJA; Kuppen, PJK; Parmiani, G
      Tumour immunotherapy: the adjuvant treatment of the 21st century?

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    31. Funaro, A; Horenstein, AL; Santoro, P; Cinti, C; Gregorini, A; Malavasi, F
      Monoclonal antibodies and therapy of human cancers

      BIOTECHNOLOGY ADVANCES
    32. Chames, P; Baty, D
      Antibody engineering and its applications in tumor targeting and intracellular immunization

      FEMS MICROBIOLOGY LETTERS
    33. Wallace, PK; Romet-Lemonne, JL; Chokri, M; Kasper, LH; Fanger, MW; Fadul, CE
      Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to Fc gamma RI and the epidermal growth factor receptor

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    34. Flieger, D; Kufer, P; Beier, I; Sauerbruch, T; Schmidt-Wolf, IGH
      A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon alpha and interleukin-2 efficiently retargets T and CD3(+)CD56(+) natural-killer-like T lymphocytes to EpCAM-expressing tumor cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    35. Takemura, S; Asano, R; Tsumoto, K; Ebara, S; Sakurai, N; Katayose, Y; Kodama, H; Yoshida, H; Suzuki, M; Imai, K; Matsuno, S; Kudo, T; Kumagai, I
      Construction of a diabody (small recombinant bispecific antibody) using a refolding system

      PROTEIN ENGINEERING
    36. Zuo, Z; Jimenez, X; Witte, L; Zhu, ZP
      An efficient route to the production of an IgG-like bispecific antibody

      PROTEIN ENGINEERING
    37. Molema, G; Kroesen, BJ; Helfrich, W; Meijer, DKF; de Leij, LFMH
      The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy

      JOURNAL OF CONTROLLED RELEASE
    38. Hoogenboom, HR; Chames, P
      Natural and designer binding sites made by phage display technology

      IMMUNOLOGY TODAY
    39. Park, SS; Ryu, CJ; Kang, YJ; Kashmiri, SVS; Hong, HJ
      Generation and characterization of a novel tetravalent bispecific antibodythat binds to hepatitis B virus surface antigens

      MOLECULAR IMMUNOLOGY
    40. Gautherot, E; Rouvier, E; Daniel, L; Loucif, E; Bouhou, J; Manetti, C; Martin, M; Le Doussal, JM; Barbet, J
      Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and I-131-labeled bivalent hapten

      JOURNAL OF NUCLEAR MEDICINE
    41. Wang, H; Liu, YJ; Wei, LX; Guo, YJ
      Bi-specific antibodies in cancer therapy

      CANCER GENE THERAPY
    42. Cochlovius, B; Kipriyanov, SM; Stassar, MJJG; Christ, O; Schuhmacher, J; Strauss, G; Moldenhauer, G; Little, M
      Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells

      JOURNAL OF IMMUNOLOGY
    43. Keler, T; Wallace, PK; Vitale, LA; Russoniello, C; Sundarapandiyan, K; Graziano, RF; Deo, YM
      Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages

      JOURNAL OF IMMUNOLOGY
    44. Helfrich, W; Haisma, HJ; Magdolen, V; Luther, T; Bom, VJJ; Westra, J; van der Hoeven, R; Kroesen, BJ; Molema, G; de Leij, L
      A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions

      JOURNAL OF IMMUNOLOGICAL METHODS
    45. Tomita, GM; Wang, Y; Paape, MJ; Poultrel, B; Rainard, P
      Influence of bispecific antibodies on the in vitro bactericidal activity of bovine neutrophils against Staphylococcus aureus

      JOURNAL OF DAIRY SCIENCE
    46. Zeidler, R; Mysliwietz, J; Csanady, M; Walz, A; Ziegler, I; Schmitt, B; Wollenberg, B; Lindhofer, H
      The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cells

      BRITISH JOURNAL OF CANCER
    47. Molema, G; Tervaert, JWC; Kroesen, BJ; Helfrich, W; Meijer, DKF; de Leij, LFMH
      CD3 directed bispecific antibodies induce increased lymphocyte-endothelialcell interactions in vitro

      BRITISH JOURNAL OF CANCER
    48. Posey, JA; Raspet, R; Verma, U; Deo, YM; Keller, T; Marshall, JL; Hodgson, J; Mazumder, A; Hawkins, MJ
      A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies

      JOURNAL OF IMMUNOTHERAPY

    49. A method for making multispecific antibodies having heteromultimeric and common components

      EXPERT OPINION ON THERAPEUTIC PATENTS
    50. Trevor, KT; Quinn, ER; Sen, M; Wankowski, D; Knox, K; LeFever, AV; Lum, LG
      Bispecific antibody reactivation of gene-transduced T cells: implications for cancer immunotherapy and gene therapy

      TUMOR TARGETING
    51. Brusselbach, S; Korn, T; Volkel, T; Muller, R; Kontermann, RE
      Enzyme recruitment and tumor cell killing in vitro by a secreted bispecific single-chain diabody

      TUMOR TARGETING
    52. Wu, AM; Williams, LE; Zieran, L; Padma, A; Sherman, M; Bebb, GG; Odom-Maryon, T; Wong, JYC; Shively, JE; Raubitschek, AA
      Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging

      TUMOR TARGETING
    53. Alpaugh, K; von Mehren, M
      Monoclonal antibodies in cancer treatment - A review of recent progress

      BIODRUGS
    54. Grunwald, F; Briele, B; Biersack, HJ
      Non-I-131-scintigraphy in the treatment and follow-up of thyroid cancer - Single-photon-emitters or FDG-PET?

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    55. Trippett, TM; Bertino, JR
      Therapeutic strategies targeting proteins that regulate folate and reducedfolate transport

      JOURNAL OF CHEMOTHERAPY
    56. Bartlett, JS; Kleinschmidt, J; Boucher, RC; Samulski, RJ
      Targeted adeno-associated virus vector transduction of nonpermissive cellsmediated by a bispecific F(ab 'gamma)(2) antibody

      NATURE BIOTECHNOLOGY
    57. Goodwin, DA; Meares, CF
      Pretargeted peptide imaging and therapy

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    58. Barbet, J; Kraeber-Bodere, F; Vuillez, JP; Gautherot, E; Rouvier, R; Chatal, JF
      Pretargeting with the Affinity Enhancement System for radioimmunotherapy

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    59. Kraeber-Bodere, F; Faivre-Chauvet, A; Sai-Maurel, C; Campion, L; Fiche, M; Gautherot, E; Le Boterff, J; Barbet, J; Chatal, JF; Thedrez, P
      Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections

      CLINICAL CANCER RESEARCH
    60. Yang, CC; Chan, HL
      Preparation and characterization of beta(1)-bungarotoxin bispecific monoclonal antibody

      BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
    61. Aalberse, RC; Schuurman, J; van Ree, R
      The apparent monovalency of human IgG4 is due to bispecificity

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    62. Haas, C; Herold-Mende, C; Gerhards, R; Schirrmacher, V
      An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules

      CANCER GENE THERAPY
    63. Classen, CF; Fulda, S; Friesen, C; Debatin, KM
      Decreased sensitivity of drug-resistant cells towards T cell cytotoxicity

      LEUKEMIA
    64. Amoroso, AR; Alpaugh, RK; Barth, MW; McCall, AM; Weiner, LM
      Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    65. Ohmi, Y; Shiku, H; Nishimura, T
      Tumor-specific targeting of T helper type 1 (Th1) cells by anti-CD3 x anti-c-ErbB-2 bispecific antibody

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    66. Watanabe, M; Wallace, PK; Keler, T; Deo, YM; Akewanlop, C; Hayes, DF
      Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210

      BREAST CANCER RESEARCH AND TREATMENT
    67. Pavlinkova, G; Beresford, GW; Booth, BJM; Batra, SK; Colcher, D
      Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts

      JOURNAL OF NUCLEAR MEDICINE
    68. Hosono, M; Hosono, MN; Kraeber-Bodere, F; Devys, A; Thedrez, P; Faivre-Chauvet, A; Gautherot, E; Barbet, J; Chatal, JF
      Two-step targeting and dosimetry for small cell lung cancer xenograft withanti-NCAM/antihistamine bispecific antibody and radioiodinated bivalent hapten

      JOURNAL OF NUCLEAR MEDICINE
    69. Kraeber-Bodere, F; Faivre-Chauvet, A; Sai-Maurel, C; Gautherot, E; Fiche, M; Campion, L; Le Boterff, J; Barbet, J; Chatal, JF; Thedrez, P
      Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft

      JOURNAL OF NUCLEAR MEDICINE
    70. Kudo, T; Suzuki, M; Katayose, Y; Shinoda, M; Sakurai, N; Kodama, H; Ichiyama, M; Takemura, S; Yoshida, H; Saeki, H; Saijyo, S; Takahashi, J; Tominaga, T; Matsuno, S
      Specific targeting immunotherapy of cancer with bispecific antibodies

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    71. Shan, DM; Press, OW; Tsu, TT; Hayden, MS; Ledbetter, JA
      Characterization of scFv-Ig constructs generated from the anti-CD20 mAb 1F5 using linker peptides of varying lengths

      JOURNAL OF IMMUNOLOGY
    72. Hudson, PJ; Kortt, AA
      High avidity scFv multimers; diabodies and triabodies

      JOURNAL OF IMMUNOLOGICAL METHODS
    73. Lu, D; Kotanides, H; Jimenez, X; Zhou, QW; Persaud, K; Bohlen, P; Witte, L; Zhu, ZP
      Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2

      JOURNAL OF IMMUNOLOGICAL METHODS
    74. Kontermann, RE; Muller, R
      Intracellular and cell surface displayed single-chain diabodies

      JOURNAL OF IMMUNOLOGICAL METHODS
    75. Morimoto, K; Inouye, K
      Method for the preparation of bispecific F(ab ')2 mu fragments from mouse monoclonal antibodies of the immunoglobulin M class and characterization ofthe fragments

      JOURNAL OF IMMUNOLOGICAL METHODS
    76. Miotti, S; Negri, DRM; Valota, O; Calabrese, M; Bolhuis, RLH; Gratama, JW; Colnaghi, MI; Canevari, S
      Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival

      INTERNATIONAL JOURNAL OF CANCER
    77. Beresford, GW; Pavlinkova, G; Booth, BJM; Batra, SK; Colcher, D
      Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody

      INTERNATIONAL JOURNAL OF CANCER
    78. Robert, B; Dorvillius, M; Buchegger, F; Garambois, V; Mani, JC; Pugnieres, M; Mach, JP; Pelegrin, A
      Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA)

      INTERNATIONAL JOURNAL OF CANCER
    79. Alt, M; Muller, R; Kontermann, RE
      Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin gamma l Fc or CH3 region

      FEBS LETTERS
    80. Fischer, R; Schumann, D; Zimmermann, S; Drossard, J; Sack, M; Schillberg, S
      Expression and characterization of bispecific single-chain Fv fragments produced in transgenic plants

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    81. Lum, LG
      T cell-based immunotherapy for cancer: A virtual reality?

      CA-A CANCER JOURNAL FOR CLINICIANS
    82. Koumarianou, AA; Hudson, M; Williams, R; Epenetos, AA; Stamp, GWH
      Development of a novel bi-specific monoclonal antibody approach for tumourtargeting

      BRITISH JOURNAL OF CANCER
    83. Colcher, D; Pavlinkova, G; Beresford, G; Booth, BJM; Choudhury, A; Batra, SK
      Pharmacokinetics and biodistribution of genetically-engineered antibodies

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    84. BABA M; HIDESHIMA T; YAMASHITA Y; SHIRAKUSA T
      POTENTIATION OF CYTOTOXICITY AGAINST A CEA POSITIVE CELL-LINE BY THE BISPECIFIC ANTIBODY OH1 USING LAK CELLS FROM CANCER-BEARING PATIENTS

      Oncology Reports
    85. ALFTHAN K
      SURFACE-PLASMON RESONANCE BIOSENSORS AS A TOOL IN ANTIBODY ENGINEERING

      Biosensors & bioelectronics
    86. Borchmann, P; Schnell, R; Diehl, V; Engert, A
      New drugs in the treatment of Hodgkin's disease

      ANNALS OF ONCOLOGY
    87. MOLEMA G; MESANDER G; KROESEN BJ; HELFRICH W; MEIJER DKF; DELEIJ LFMH
      ANALYSIS OF IN-VITRO LYMPHOCYTE ADHESION AND TRANSENDOTHELIAL MIGRATION BY FLUORESCENT-BEADS-BASED FLOW CYTOMETRIC CELL COUNTING

      Cytometry
    88. Gruner, BA; Weitman, SD
      The folate receptor as a potential therapeutic anticancer target

      INVESTIGATIONAL NEW DRUGS
    89. HOSONO M; HOSONO MN; KRAEBERBODERE F; DEVYS A; THEDREZ P; FICHE M; GAUTHEROT E; BARBET J; CHATAL JF
      BIODISTRIBUTION AND DOSIMETRIC STUDY IN MEDULLARY-THYROID CANCER XENOGRAFT USING BISPECIFIC ANTIBODY AND IODINE-125-LABELED BIVALENT HAPTEN

      The Journal of nuclear medicine
    90. GAUTHEROT E; LEDOUSSAL JM; BOUHOU J; MANETTI C; MARTIN M; ROUVIER E; BARBET J
      DELIVERY OF THERAPEUTIC DOSES OF RADIOIODINE USING BISPECIFIC ANTIBODY-TARGETED BIVALENT HAPTENS

      The Journal of nuclear medicine
    91. BERA TK; ONDA M; BRINKMANN U; PASTAN I
      A BIVALENT DISULFIDE-STABILIZED FV WITH IMPROVED ANTIGEN-BINDING TO ERBB2

      Journal of Molecular Biology
    92. CHAU LA; BLUESTONE JA; MADRENAS J
      DISSOCIATION OF INTRACELLULAR SIGNALING PATHWAYS IN RESPONSE TO PARTIAL AGONIST LIGANDS OF THE T-CELL RECEPTOR

      The Journal of experimental medicine
    93. RIEDLE S; ROSEL M; ZOLLER M
      IN-VIVO ACTIVATION AND EXPANSION OF T-CELLS BY A BI-SPECIFIC ANTIBODYABOLISHES METASTASIS FORMATION OF HUMAN-MELANOMA CELLS IN SCID MICE

      International journal of cancer
    94. MULLER KM; ARNDT KM; PLUCKTHUN A
      A DIMERIC BISPECIFIC MINIANTIBODY COMBINES 2 SPECIFICITIES WITH AVIDITY

      FEBS letters
    95. MULLER KM; ARNDT KM; STRITTMATTER W; PLUCKTHUN A
      THE FIRST CONSTANT DOMAIN (C(H)1 AND C-L) OF AN ANTIBODY USED AS HETERODIMERIZATION DOMAIN FOR BISPECIFIC MINIANTIBODIES

      FEBS letters
    96. ROOVERS RC; HENDERIKX P; HELFRICH W; VANDERLINDEN E; REURS A; DEBRUINE AP; ARENDS JW; DELEIJ L; HOOGENBOOM HR
      HIGH-AFFINITY RECOMBINANT PHAGE ANTIBODIES TO THE PAN-CARCINOMA MARKER EPITHELIAL GLYCOPROTEIN-2 FOR TUMOR TARGETING

      British Journal of Cancer
    97. GEORGE AJT; GALLOP JL; RASHID M
      KINETICS OF BIOMOLECULAR INTERACTIONS

      Expert opinion on therapeutic patents
    98. CHO BK; ROY EJ; PATRICK TA; KRANZ DM
      SINGLE-CHAIN FV FOLATE CONJUGATES MEDIATE EFFICIENT LYSIS OF FOLATE-RECEPTOR-POSITIVE TUMOR-CELLS/

      Bioconjugate chemistry
    99. HAAS C; SCHIRRMACHER V
      EFFECTIVE INTRODUCTION OF T-CELL COSTIMULATORY MOLECULES INTO VIRUS MODIFIED TUMOR-CELL VACCINES BY MODIFICATION WITH BISPECIFIC ANTIBODIES

      International journal of oncology
    100. SCOTT AM; WELT S
      ANTIBODY-BASED IMMUNOLOGICAL THERAPIES

      Current opinion in immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 07:35:56